Dr. Matthew Russell Smeds, MD

Dr. Smeds practices at SSM Health Saint Louis University Hospital in Saint Louis, Missouri, part of SSM Health Care.

Dr. Smeds' NPI, 1003067240, was assigned on October 7, 2008. Dr. Smeds graduated from University of Rochester School of Medicine and Dentistry in 2005. Dr. Smeds holds Missouri license 2010011922.

Dr. Smeds' primary practice is SSM Health Saint Louis University Hospital, at 1201 S Grand Blvd, Saint Louis, MO 63104 in St. Louis City. The practice phone is (314) 257-8000.

Dr. Smeds' primary practice is SSM Health Saint Louis University Hospital in Saint Louis, Missouri, part of SSM Health Care. Dr. Smeds is also affiliated with SSM Health St. Mary's Hospital - St. Louis. The medical group on file is SLUCare Physician Group. Dmand AI also links Dr. Smeds to 1 more hospital, 2 group practices and clinics, 1 behavioral health center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Smeds practices, 6 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Smeds' primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Smeds is licensed in Missouri.

CMS data shows 349 Medicare services from Dr. Smeds across 10 procedure codes in 2024, for 310 Medicare patients. Medicare paid $11,026 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 310 Medicare patients who saw Dr. Smeds in 2024. The largest group is 65 to 74, with 148 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 39% are also on Medicaid. Their average risk score is 3.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Smeds' median patient age at 68, with 48% women.

In 2024, Dr. Smeds wrote 106 Medicare Part D claims for 40 patients. 85% of them were for generic drugs. CMS names the drug for 88 of them, across 4 drugs with 11 or more claims each, at $11,860 in total drug cost. In 2023, CMS named 100 claims across 4 drugs.

Dr. Smeds accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 91 papers to Dr. Smeds, published from 2011 to 2025. 2024 was the busiest year, with 13. The most frequent topics are Vascular Surgical Procedures, Endovascular Procedures and Surgeons. Dr. Smeds has published most often in Ann Vasc Surg. Dr. Smeds' most frequent co-authors are Mohammed Mahmoud Moursi, MD, Catherine M. Wittgen, MD and Saideep Bose, MD.

Dmand AI links Dr. Smeds to 10 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Adenocarcinoma of Lung, Biliary Atresia and Low Back Pain.

CMS Open Payments shows 354 general payments to Dr. Smeds from 35 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 76% of the total. W. L. Gore & Associates, Inc. paid the most, $4,888.

Dr. Smeds graduated from University of Rochester School of Medicine and Dentistry in 2005.